Bridgewater Advisors Inc. Mustang Bio, Inc. Transaction History

Bridgewater Advisors Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$1.66 - $2.64 $74,700 - $118,800	-45,000 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$2.58 - $3.36 $12,900 - $16,800	5,000 Added 12.5%	45,000 $121,000
Q2 2021 Aug 06, 2021	BUY	$2.7 - $3.81 $108,000 - $152,400	40,000 New	40,000 $133,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Bridgewater Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Bridgewater Advisors Inc. with notifications on news.